WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Stock Ownership - Who owns Editas Medicine?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Editas Medicine Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gilmore Neil OneillCEO2025-12-035,603$2.15
$12.06kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-12-03713$2.15
$1.54kSell
Amy ParisonSVP Chief Financial Officer2025-12-03461$2.15
$992.53Sell
Gilmore Neil OneillCEO2025-09-035,592$2.60
$14.52kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-09-03710$2.60
$1.84kSell
Amy ParisonSVP Chief Financial Officer2025-09-03458$2.60
$1.19kSell
Amy ParisonSVP Chief Financial Officer2025-08-07679$2.58
$1.75kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-07-315,121$2.49
$12.76kSell
Gilmore Neil OneillCEO2025-06-0315,192$1.72
$26.19kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-06-03726$1.72
$1.25kSell

1 of 2

EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDIT insiders and whales buy or sell their stock.

EDIT Shareholders

What type of owners hold Editas Medicine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.22%8,019,891$16.12MInstitution
Vanguard Group Inc7.14%6,965,618$14.00MInstitution
Kevin P. Starr4.00%3,906,176$7.85MInsider
Third Rock Ventures III LP4.00%3,906,176$7.85MInsider
Polaris Venture Management Co VI LLC3.89%3,797,144$7.63MInsider
Viking Global Investors LP3.07%2,996,590$6.02MInsider
Kevin Bitterman2.87%2,797,144$5.62MInsider
Flagship Ventures Fund IV LP2.85%2,786,967$5.60MInsider
Boris Nikolic2.75%2,684,572$5.40MInsider
Bng0 LLC2.71%2,649,572$5.33MInsider

1 of 3

EDIT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDIT44.12%33.76%Net SellingNet Selling
ZNTL62.97%37.03%Net SellingNet Selling
SRZN23.63%76.37%Net BuyingNet Buying
CCCC54.21%18.64%Net SellingNet Buying
ARCT87.51%12.49%Net Buying
View Top Biotech Stocks

Editas Medicine Stock Ownership FAQ

Who owns Editas Medicine?

Editas Medicine (NASDAQ: EDIT) is owned by 44.12% institutional shareholders, 33.76% Editas Medicine insiders, and 22.12% retail investors. Kevin P. Starr is the largest individual Editas Medicine shareholder, owning 3.91M shares representing 4.00% of the company. Kevin P. Starr's Editas Medicine shares are currently valued at $8.05M.

If you're new to stock investing, here's how to buy Editas Medicine stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.